LUNG ADENOSQUAMOUS CARCINOMA
Clinical trials for LUNG ADENOSQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG ADENOSQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG ADENOSQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New cocktail for tough lung cancer shows promise in small trial
Disease control OngoingThis phase 2 pilot trial tested adding the drug bevacizumab to standard chemotherapy and radiation for patients with stage III non-small cell lung cancer that cannot be removed by surgery. The study enrolled 29 newly diagnosed patients to see if the combination is safe and helps …
Matched conditions: LUNG ADENOSQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Radiation plus immunotherapy: a new hope for hard-to-treat lung cancer?
Disease control TerminatedThis study is for people with advanced non-small cell lung cancer that does not have the PD-L1 marker, making it harder to treat with immunotherapy alone. The trial compares standard immunotherapy (with or without chemotherapy) to the same treatment plus radiation therapy. The go…
Matched conditions: LUNG ADENOSQUAMOUS CARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC